+1,100.9%
MRNA vs AMC
-97.6%
+1,198.5%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | AMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.7% | -0.8% | -3.3% |
| 7D | -12.1% | +3.5% | -15.6% | -12.3% |
| 30D | -1.3% | +12.5% | -13.8% | -1.7% |
| 3M | +250.9% | +23.6% | +227.4% | +247.9% |
| 6M | +343.0% | +144.4% | +198.7% | +324.0% |
| YTD | +657.4% | +108.3% | +549.1% | +627.0% |
| 1Y | +794.9% | +38.9% | +756.0% | +772.9% |
| 3Y | +218.1% | -58.9% | +277.0% | +218.3% |
| 5Y | -3.4% | -99.2% | +95.8% | +3.2% |
| All | +1,100.9% | -97.6% | +1,198.5% | +1,369.2% |
Cumulative growth
Daily Returns
Daily percentage return beside AMC.
Daily Out/Under-Performance
Portfolio return minus AMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded AMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling